Comparison of topically administered 0.05% difluprednate and 1% prednisolone acetate for inhibition of aqueocentesis-induced breakdown of the blood-aqueous barrier in healthy dogs.

CONCLUSIONS AND CLINICAL RELEVANCE: All 4 treatments were effective for reducing aqueocentesis-induced anterior uveitis in healthy dogs regardless of the drug or frequency of administration. Topical ophthalmic administration of 0.05% difluprednate may be a viable treatment option for dogs with anterior uveitis and warrants further study. PMID: 32101036 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32101036?dopt=Abstract

Source: American Journal of Veterinary Research - February 28, 2020 Category: Veterinary Research Authors: Allbaugh RA, Wehrman RF, Sebbag L Tags: Am J Vet Res Source Type: research